Got $1,000? 2 Healthcare Stocks to Buy and Hold Forever.

Group 1: Pfizer - Pfizer has faced challenges due to declining coronavirus-related revenue and upcoming patent cliffs, including the loss of exclusivity for key products like Eliquis [2][3] - The company has transformed its business through acquisitions and divestitures, resulting in a robust pipeline of new products and approvals [2][3] - Pfizer's vaccine pipeline includes over a dozen programs, with candidates targeting diseases like Lyme disease, which currently lacks an approved vaccine in the U.S. [3] - The company has demonstrated strong management and innovation, exemplified by the rapid development of Paxlovid and its partnership with BioNTech for the COVID-19 vaccine [3] - Pfizer offers a dividend yield exceeding 5.75%, making it an attractive option for dividend investors [4] Group 2: Intuitive Surgical - Intuitive Surgical has received clearance for the fifth generation of its da Vinci robotic-assisted surgery system, leading to strong demand and financial performance [5][6] - The company reported a 17% year-over-year revenue growth to $2.04 billion, with da Vinci procedure volume increasing by 18% [5] - Intuitive Surgical is the leader in the robotic-assisted surgery market, benefiting from the advantages of minimally invasive procedures [6] - The installed base of da Vinci systems grew by 15% year-over-year, indicating strong market presence and customer retention [6] - The aging population is expected to drive long-term growth in procedure volume for Intuitive Surgical, reinforcing its competitive position in the industry [6]